The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
OBN Press Releases
Wickham Laboratories Ltd will exhibit on Stand 309 at the Making Pharmaceuticals Conference on 24th – 25th April 2018 at Ricoh Arena, Coventry.
Read the rest of entry »
OBN Launch BioForward® Conference - a unique, high-quality, international conference, focussed on creating and developing a practical roadmap for early stage, emerging, and developing companies to achieve sustainable business success and growth.
Wickham Laboratories Ltd will exhibit on Stand 408 at the Making Pharmaceuticals Europe Conference, from the 13th - 14th March 2018 in Belgium at Brussels Expo centre.
Making Pharmaceutical Europe offers a free to attend exhibition and conference featuring many companies who are involved within the pharmaceutical industry.
This will be the exhibition’s inaugural event in Europe and we are proud to be supporting the expansion of the Making Pharmaceuticals tradeshow.
Dr Lynne Murdoch, our head of microbiology, will also be contributing to the conference seminar programme with a discussion on the merits of rapid microbiological testing. This presentation, MALDI-ToF in Practice; Validated Application of a Rapid Microbiological Method, will take place on 13 March at 10:10AM, Room B of the Brussels Expo centre.
Join Dr Murdoch for this exciting discussion on MALDI-ToF as a quicker and more reliable method of microbial identification or visit Stand 408 to discuss your specific contract testin ...
Wickham Laboratories is pleased to announce the publication of a thought leadership piece on “Rapid Testing Methods: the cost-effective safety solution” which was featured in European Pharmaceutical Review’s December 2017 issue.
BioSeed® has been designed to provide a platform for innovative life science companies to present and meet with sector specific early stage investors.
OBN Awards 2017 – Winners Recognised at Industry Leading Event
Abingdon, UK, 6 October 2017: – OBN (UK) Ltd, the membership organisation that supports the life sciences industry, are delighted to announce the winners of the prestigious OBN Awards 2017 that were presented last night in front of a sold-out audience of over 250 life science industry leaders at the Town Hall in Oxford.
The Awards, which are in their 9th year, celebrate the best of UK life sciences – from outstanding scientific innovation within biotech, medtech, digital, synthetic biology, to the companies that support the industry and the fundraisers that make it happen.
John Harris, CEO of OBN, said: “We received an outstanding number of entries this year; up a staggering 120% on last year, so competition was really tough. All of our winners and nominees this year are truly innovative and set a great example to the rest of the industry. We ...
BioSeed®, a new conference created by OBN and Eurasanté, aims to showcase Europe’s most innovative early stage life sciences companies
26 July 2017, Abingdon, UK: OBN, the membership organisation supporting the UK’s innovative life sciences companies, is pleased to announce today that EY, global leader in assurance, tax, transaction and advisory services, has confirmed their support as Official Host of the first BioSeed® conference, taking place in London on 14 November 2017.
BioSeed® is the result of a shared vision between OBN and Eurasanté; with both parties aiming to fill the gap of industry events that solely support the interaction of early-stage companies with appropriate investors at a European level.
BioSeed® will run as a one-day event at EY's 1 More London Place office, on 14 November 2017 and will feature presentations and pitches by early-stage organisations and a series of pre-scheduled one-to-one meetings with potential investors.
Abingdon, UK: OBN the membership organisation supporting the UK’s innovative life sciences companies, announces today the appointment of Bill Fleming to its Board of Directors, effective immediately
Abingdon, UK - OBN, the membership organisation supporting the UK’s innovative life sciences companies is pleased to announce today that Venner Shipley, a leading firm of European patent & trade mark attorneys and IP lawyers, has become OBN’s exclusive patent and trade mark attorney sponsor.
Abingdon, UK - OBN, the Membership organisation supporting the UK’s innovative life sciences companies, announced today the appointment of Mark Hooper as the new Head of Business Development with immediate effect.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, email@example.com, and we will post.